Mind Medicine to Join Nasdaq Biotechnology Index

MT Newswires Live12-19

Mind Medicine (MNMD) said Thursday that it is set to join the Nasdaq Biotechnology Index on Monday.

Companies are selected annually in December for the Nasdaq Biotechnology Index based on specific eligibility criteria, including their classification as biotechnology or pharmaceutical companies under the Industry Classification Benchmark, according to Mind Medicine.

Price: 7.24, Change: +0.01, Percent Change: +0.14

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment